XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]        
Total revenues $ 18,149 $ 36,031 $ 129,752 $ 141,542
Cost of revenues (excluding amortization and depreciation) 3,948 12,694 40,344 29,097
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 226,520 178,565 858,582 453,642
General and administrative expense and Salaries and benefits (excluding stock based compensation and amortization expense) 779,900 547,606 2,089,859 1,787,487
Amortization 5,473 4,211 15,385 10,666
Stock based compensation 1,082,790 1,539,169 2,291,734 2,008,801
Professional fees 265,149 262,303 811,562 731,099
Interest income, net (2,288) (1,000) (8,081) (1,370)
Equity in net (income) loss from equity method investees (159) 1,048 (4,651)
Other income (67,032) (59,101) (125,046) (99,322)
Segment net loss (2,276,311) (2,448,257) (5,845,635) (4,773,907)
Reconciliation of net loss        
Adjustments and reconciling items
Consolidated net loss (2,276,311) (2,448,257) (5,845,635) (4,773,907)
Clinical trials [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 33,505 50,000 235,083 60,825
Halo Project [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 128,935 94,418 517,506 316,194
Desktop Project [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): 11,700 34,147 47,113 75,671
Other research and development [Member]        
Research and development expense (excluding share-based compensation expense):        
Research and development expense (excluding share-based compensation expense): $ 52,380 $ 58,880 $ 952